United Therapeutics (TETON-OLE) RIN-PF-302

Who Can Participate?

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease RIN-PF-302
TETON-OLE

Principal Investigator

Lake
Morrison

Protocol Number

PRO00118391

NCT ID

NCT04905693

Phase

III

Enrollment Status

Open to Enrollment